Dr. Mark Christopher Austin is a Leland, North Carolina based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 2001 S. Baxter Drive, Leland. Patients can reach him at 910-769-1605.
Dr. Mark Christopher Austin deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Mark Christopher Austin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Mark Christopher Austin
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S.
Accepts Medicare Assignment:
May Accept
Practice Address:
2001 S. Baxter Drive, Leland, North Carolina, 28451-9999
Phone:
910-769-1605
Fax:
910-772-9452
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
9133211717
Enrollment ID:
I20160226001025
NPI Number:
1457427924
NPI Enumeration Date:
28 Nov, 2006
NPI Last Update On:
06 Feb, 2014
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2001 S. Baxter Drive, Leland, North Carolina
Zip:
28451-9999
Phone Number:
910-769-1605
Fax Number:
910-772-9452
Patients can reach Dr. Mark Christopher Austin at 2001 S. Baxter Drive, Leland, North Carolina or can call to book an appointment on 910-769-1605. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.